A federal multidistrict litigation (MDL) court in Maryland has dismissed without prejudice the consolidated amended complaint filed by eight named
Applying Maryland law, the United States District Court for the District of Maryland has held that an insurer must demonstrate prejudice to support a
In an opinion issued yesterday, Judge Althea Handy of the Maryland Business and Technology Case Management Program in the Circuit Court for Baltimore
On August 8, 2011, the U. S. Court for the District of Maryland granted in part, and denied in part, a motion under Rule 12(b)(6), F.R.C.P., to dismiss claims of trademark and trade dress infringement, trade secret misappropriation and unfair competition
On April 13, 2011, a federal grand jury in Maryland returned an indictment charging Lauren Stevens, formerly a vice president and associate general counsel for GlaxoSmithKline (GSK), with obstruction of justice and making false statements to the Food and Drug Administration (FDA) in connection with an investigation into allegations that the drug Wellbutrin had been marketed for unapproved uses.
In Sherwood Brands, Inc. v. Great American Ins. Co., No. 62 (Md. Feb. 24, 2011), the Maryland Court of Appeals re-affirmed Maryland's long-standing public policy - embraced by both the courts and the legislature since 1964 - that an insurer cannot deny coverage based on late notice, unless the insurer can prove that it was prejudiced.
As previously reported, media and legal analysts speculated that the November 8, 2010 indictment of former GlaxoSmithKline vice-president and associate general counsel Lauren Stevens would have a chilling effect on the lawyers and executives in the pharmaceutical industry.
On March 23, 2011, United States District Judge Roger Titus in Greenbelt, Maryland dismissed the indictment of former GlaxoSmithKline in-house counsel Lauren Stevens because prosecutors erroneously instructed the grand jury that the advice of counsel defense did not apply until trial.
On March 23, 2011, the United States District Court for the District of Maryland dismissed without prejudice the prosecution of Lauren Stevens, former GlaxoSmithKline Vice President and Associate General Counsel.
Yesterday, a federal district court for the District of Maryland issued an opinion dismissing without prejudice the indictment against former GSK in-house attorney Lauren Stevens accusing her of obstruction and making false statements in connection with an FDA inquiry concerning the company's marketing practices for Wellbutrin.